In a Letter to the Editor published yesterday by the Journal of Translational Medicine, I describe my hypotheses about a key source of pain and inflammation in #MECFS that may also play a role in post-exertional malaise (#PEM). 1/ …nslational-medicine.biomedcentral.com/articles/10.11…
My hypotheses are grounded in experience as a caretaker for my daughter with hypermobility Ehlers-Danlos Syndrome (#EDS), #MECFS, #POTS, #Chiari malformation, and #craniocervical instability and my reading of the #MECFS and #lipedema literatures. May also apply to #LongCovid 2/
In a nutshell, my hypothesis is that vascular damage and/or endothelial dysfunction causes interstitial fluid to leak from blood vessels of people with #MECFS, leading to formation of adipose tissue that becomes fibrotic, causing inflammation, hypoxia & widespread pain. 3/
This is the other half of the equation posited by Wirth, Scheibenbogen, and Paul, as well as others, who argue that the neurological symptoms of #MECFS are the result of reduced blood volume stemming from this leakage & endothelial dysfunction. 4/ …nslational-medicine.biomedcentral.com/articles/10.11…
I also propose that leakage of interstitial fluid plays a role in post-exertional malaise by flooding affected tissue, leading to hypoxic conditions. The leakage increases with movement/exercise and when fluid volume is increased as a result of elevated cortisol or estrogen. 5/
The letter is fairly short, so I won’t summarize further here. But if you’d prefer a tweet threat, I covered much of the same ground here: 6/
A huge thank you to everyone who commented on the earlier tweet thread and on my Health Rising post exploring the connections between #lipedema, #MECFS, #fibromyalgia, and #EDS. These comments were really helpful in refining the hypotheses. 7/ healthrising.org/blog/2021/12/0…
I would encourage researchers to rigorously evaluate these hypotheses and would equally welcome research that confirms or refutes them. I could well be wrong. But if I’m right, or partially right, the hypotheses would suggest new paths for treatment and research. 8/
Some immediate treatments that could help include manual lymphatic drainage, squeezing of affected tissue, & manual techniques to break-up fibrotic adipose tissue. I am hopeful that researchers could also discover more systemic (and less painful) ways to treat the fibrosis. 9/
Research is needed on the incidence and extent of fibrotic adipose tissue in people with #MECFS compared with controls. The methodology used here to identify subcutaneous adipose tissue in different parts of the body may provide a model. 10/ nature.com/articles/ijo20…
Additional research examining whether and to what extent manual lymphatic drainage, the squeezing of affected tissue, and the manual breakup of fibrotic adipose tissue are helpful for people with #MECFS, #LongCovid, #EDS and #Fibromyalgia would also be very helpful. 11/
I would strongly recommend that researchers studying #MECFS, hypermobile #EDS, #Fibromyalgia and #LongCovid reach out to researchers studying #lipedema to discuss ways the literatures could inform each other. 13/
There appear to be high rates of hypermobility in #EDS, #Fibromyalgia, and #MECFS, suggesting that connective tissue disorders may play a role in each. (Citations collected in my Health Rising piece; search for "overlap"). 14/ healthrising.org/blog/2021/12/0…
The usual caveats apply: I am not a doctor; I do not have medical training; I cannot provide medical advice. For more background on what I’m trying to accomplish, see this blog post: 15/ blogs.bmj.com/bmj/2021/09/20…
Elevated estrogen levels upregulate the production of histamine, which increases vascular permeability. This may be another reason for increased challenges at ovulation and before period. See pubmed.ncbi.nlm.nih.gov/22112012/ and ncbi.nlm.nih.gov/labs/pmc/artic… 5.1/
@BendyBrain -- I was just reading your Beyond Bones paper and thought it would be extraordinarily helpful to get your feedback on this blog on possible connections between the 3 disorders you examine (MECFS, Fibro, and EDS) and lipedema. Would welcome an opportunity for dialogue!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
By far, the most important events in the lifecourse of my daughter's #MECFS were two massive relapse events that severely degraded her baseline level of functioning. Hoping to crowdsource ideas from #Medtwitter and #NEISVoid on this phenomenon and how to study it effectively. 1/
A better understanding of exactly what happens during these events would help us make faster progress in understanding #MECFS and perhaps #LongCOVID. Yet this phenomenon remains dramatically understudied. We need to change this! 2/
The field lacks clear and uniform terminology for describing these events, which is one of many obstacles to studying them. For now I have settled on the term "massive relapse event" for these reasons: 3/
A question for people with #MECFS or #LongCOVID: in your experience, is post-exertional malaise a single phenomenon? Or is it possible there are distinct phenomena that are not being adequately distinguished, impeding understanding? #NEISvoid
With my daughter -- who has #hEDS, #MECFS, #POTS, etc. -- we have observed at least 2 and possibly 3 separate phenomena that all seem to fit the description of #PEM. Let's call them (a) "major crash," (b) "day to day PEM" and (3) "cumulative exertion PEM"
She has had 2 major crashes. These were biphasic events that appear to have caused severe damage lasting years. First major crash (2017) was what made us aware of her illness. She felt very hot in the morning. Then, some time after a long hike, she had whole-body chills/shaking.
This thread outlines my hypotheses on how leakages from microangiographic blood vessels contribute to pain, inflammation and post-exertional malaise in people w/ #MECFS and #LongCOVID. This mechanism is most pronounced in people with a connective tissue disorder. 1/
The core of my hypotheses is that COVID-19 or other viruses cause damage to endothelial cells in blood vessels, which increase their permeability, leading to the release of interstitial fluid which floods affected tissue, creating hypoxic conditions that trigger inflammation. 2/
The increased interstitial fluid eventually forms subcutaneous adipose tissue, which becomes fibrotic and painful to touch, leading to additional inflammation that releases mast cell mediators that cause further endothelial damage, in a worsening spiral. 3/
I have tried to assemble the evidence base to support conducing an RCT of high-dose thiamine for people with #MECFS, #Fibromyalgia and #EDS. I would appreciate feedback on whether the case has been made, and if not, what additional evidence would help.
The medical journal Alimentary Pharmacology & Therapeutics published my letter to the editor today exploring some hypotheses on why high-dose thiamine may reduce fatigue in patients with diverse immunological and neurological conditions. onlinelibrary.wiley.com/doi/full/10.11….
My hypotheses focus on the role of high-dose thiamine in inhibiting carbonic anhydrase isoenzymes. pubmed.ncbi.nlm.nih.gov/22145674/ . At present this has been shown only in vitro, so studies in humans are needed to confirm.